의약품 관련 법령
Resolution RDC 233: Amends RDC 102/2016 on Marketing Authorization and Clinical Trial Transfers
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2018-06-20 | 조회수 | 635 |
국가정보 | 남 아메리카>브라질 | ||
출처 | ANVISA | ||
원문 | http://portal.anvisa.gov.br | ||
첨부파일 |
Resolution RDC 233: Amends RDC 102/2016 on Marketing Authorization and Clinical Trial Transfers
- 이전글 Resolution RDC 231: Amends Order 344/1998 Technical Regulations for Substances and Medicinal Products Subject to Special Control
- 다음글 Resolution RDC 235: Establishes Quality Control Requirements for the Registration and Post-Registration of Dynamized, Herbal and Specific Medicinal Products and Biological Products